Biol, Florencia .
HRN: 09-33-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2022
CEFUROXIME 1.5GM (VIAL)
10/10/2022
10/16/2022
IVTT
1.5gm
Q8H
S/p EL TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes